Deep Brain Stimulation for Dystonia in Children

Status: draft · Last updated 2026-11-02 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Target: the posteroventral GPi. Bilateral GPi is the standard for childhood dystonia .
  • Coordinates: start about 20–22 mm lateral, 2–4 mm anterior to the midcommissural point and 2–4 mm below AC–PC, then refine on MRI. The internal capsule is medial and the optic tract below. Use the pallidocapsular line and the optic tract as the landmarks .
  • Asleep, image-verified placement gives sub-millimeter to 1–2 mm accuracy in children .
  • Programming: improvement builds over months. Shorter pulse widths save battery and may limit bradykinesia .
  • Best candidates: inherited or idiopathic dystonia without brain injury, especially TOR1A, about 70% improvement .
  • Less predictable: THAP1 and KMT2B (less sustained), and PKAN (classic about 16%) .
  • Dyskinetic cerebral palsy: about 24% motor improvement, but meaningful goal gains are possible. Set expectations carefully .
  • Operate earlier: a shorter disease duration predicts a better result .
  • Status dystonicus: DBS resolves it in nearly all reported cases, with lower mortality than medical treatment .
  • Risk: major complications in about 16% of children treated for movement disorders, with higher risk in small, urgent cases. In the US, the device exemption covers children 7 and older .

Pallidal (GPi) deep brain stimulation is an established treatment for medically refractory dystonia in children. How well it works depends mostly on the cause of the dystonia. Inherited and idiopathic dystonias without structural brain injury respond best; acquired (dyskinetic cerebral palsy) and degenerative dystonias respond less.

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:dbs_response:1e52ed3994adb13d© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Mean percent improvement in Burke-Fahn-Marsden movement score after pallidal deep brain stimulation, by cause of dystonia0%25%50%75%mean improvement in BFMDRS-MTOR1A (DYT1)70%SGCE (myoclonus-dystonia)63%THAP1 (DYT6)52%PKAN, atypical45%KMT2B38%GNAO138%Dyskinetic cerebral palsy24%PKAN, classic16%
Mean improvement in the Burke-Fahn-Marsden movement score (BFMDRS-M) after pallidal DBS, by cause. TOR1A, SGCE, THAP1 and KMT2B: 1 year, individual-patient meta-analysis . PKAN: 1 year . GNAO1: last follow-up . Dyskinetic cerebral palsy: median 12 months . The studies differ in design and follow-up, so compare them as a rough guide.

Who gets it

Outcomes by cause

Predictors of a good result

Targeting the GPi

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:gpi_target:6e912ca4de05dd13© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Coronal section of one hemisphere (midline at left) through the pallidal target: putamen, GPe and GPi, the internal capsule medial to GPi, the optic tract just below it, thalamus and lateral ventricle, and a DBS lead whose contacts lie in the ventral GPilateralventriclethalamusinternalcapsuleoptic tractDBS leadputamenGPeGPicontacts inventral GPiinsulamidline
Schematic coronal section of one hemisphere (midline at left) near the pallidal target. The internal capsule lies medial to GPi and the optic tract just beneath it; the lead ends in the ventral GPi. Not to scale.

Surgical technique in children

Programming

Status dystonicus

Complications

Related topics

References

  1. Jung S, Molot-Toker S, Dinger TF, et al. Safety, feasibility, and outcomes of deep brain stimulation in young children excluded from the FDA Humanitarian Device Exemption: analysis of the CHILD-DBS registry. J Neurosurg Pediatr 2026;38(4):430–441. doi:10.3171/2026.2.PEDS25517. PMID 42566800. verified
  2. Lumsden DE, Ramiah R, Smallbone T, et al. Deep brain stimulation in the management of movement disorders in childhood: a UK-wide cross-sectional study. Arch Dis Child 2026;111(2):147–152. doi:10.1136/archdischild-2025-328889. PMID 41093365. verified
  3. Duga V, Giossi R, Romito LM, et al. Long-term globus pallidus internus deep brain stimulation in pediatric non-degenerative dystonia: a cohort study and a meta-analysis. Mov Disord 2024;39(7):1131–1144. doi:10.1002/mds.29815. PMID 38646731. verified
  4. Elkaim LM, Alotaibi NM, Sigal A, et al. Deep brain stimulation for pediatric dystonia: a meta-analysis with individual participant data. Dev Med Child Neurol 2019;61(1):49–56. doi:10.1111/dmcn.14063. PMID 30320439. verified
  5. Koy A, Hellmich M, Pauls KA, et al. Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis. Mov Disord 2013;28(5):647–654. doi:10.1002/mds.25339. PMID 23408442. verified
  6. Brüggemann N, Kühn A, Schneider SA, et al. Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology 2015;84(9):895–903. doi:10.1212/WNL.0000000000001312. PMID 25653290. verified
  7. Cif L, Demailly D, Lin JP, et al. KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation. Brain 2020;143(11):3242–3261. doi:10.1093/brain/awaa304. PMID 33150406. verified
  8. Badhiwala JH, Karmur B, Elkaim LM, et al. Clinical phenotypes associated with outcomes following deep brain stimulation for childhood dystonia. J Neurosurg Pediatr 2019;24(4):442–450. doi:10.3171/2019.5.PEDS1973. PMID 31299640. verified
  9. Decraene B, Smeets S, Remans D, et al. Deep brain stimulation for GNAO1-associated dystonia: a systematic review and meta-analysis. Neuromodulation 2024;27(3):440–446. doi:10.1016/j.neurom.2023.10.187. PMID 37999699. verified
  10. De Vloo P, Lee DJ, Dallapiazza RF, et al. Deep brain stimulation for pantothenate kinase-associated neurodegeneration: a meta-analysis. Mov Disord 2019;34(2):264–273. doi:10.1002/mds.27563. PMID 30633810. verified
  11. Vidailhet M, Yelnik J, Lagrange C, et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol 2009;8(8):709–717. doi:10.1016/S1474-4422(09)70151-670151-6). PMID 19576854. verified
  12. Koy A, Kühn AA, Huebl J, et al. Quality of life after deep brain stimulation of pediatric patients with dyskinetic cerebral palsy: a prospective, single-arm, multicenter study with a subsequent randomized double-blind crossover (STIM-CP). Mov Disord 2022;37(4):799–811. doi:10.1002/mds.28898. PMID 34967053. verified
  13. Koy A, Kühn AA, Schiller P, et al. Long-term follow-up of pediatric patients with dyskinetic cerebral palsy and deep brain stimulation. Mov Disord 2023;38(9):1736–1742. doi:10.1002/mds.29516. PMID 37358761. verified
  14. Barkey S, Ainaga L, Navarrete Muñoz EM, et al. Deep brain stimulation outcomes and management of childhood-onset dystonia and associated hyperkinetic movements disorders. Dev Med Child Neurol 2026 (online ahead of print). doi:10.1111/dmcn.70481. PMID 42658563. verified
  15. Vogt LM, Yan H, Santyr B, et al. Deep brain stimulation for refractory status dystonicus in children: multicenter case series and systematic review. Ann Neurol 2024;95(1):156–173. doi:10.1002/ana.26799. PMID 37714824. verified
  16. Vogt LM, Yang K, Tse G, et al. Recommendations for the management of initial and refractory pediatric status dystonicus. Mov Disord 2024;39(9):1435–1445. doi:10.1002/mds.29794. PMID 38619077. verified
  17. Balachandar A, Verhey LH, Mithani K, et al. Surgical complications of deep brain stimulation in children across targets and indications: multicenter analysis of the CHILD-DBS registry. Neurology 2025;105(9):e214201. doi:10.1212/WNL.0000000000214201. PMID 41071966. verified
  1. Starr PA, Turner RS, Rau G, et al. Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. Neurosurg Focus 2004;17(1):E4. doi:10.3171/foc.2004.17.1.4. PMID 15264773. verified
  2. Reich MM, Horn A, Lange F, et al. Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study. Brain 2019;142(5):1386–1398. doi:10.1093/brain/awz046. PMID 30851091. verified
  3. Cheung T, Noecker AM, Alterman RL, et al. Defining a therapeutic target for pallidal deep brain stimulation for dystonia. Ann Neurol 2014;76(1):22–30. doi:10.1002/ana.24187. PMID 24852850. verified
  4. Lumsden DE, Tambirajoo K, Hasegawa H, et al. Probabilistic mapping of deep brain stimulation in childhood dystonia. Parkinsonism Relat Disord 2022;105:103–110. doi:10.1016/j.parkreldis.2022.11.006. PMID 36403506. verified
  5. Huh R, Jang I. Accuracy and outcomes of KYMERO robot-guided deep brain stimulation for dystonia: retrospective cohort analysis. J Korean Neurosurg Soc 2026;69(4):616–629. doi:10.3340/jkns.2025.0212. PMID 41582458. Full text (PMC) verified
  6. Jin ST, Lee MK, Ghang JY, et al. Deep brain stimulation of the globus pallidus in a 7-year-old girl with DYT1 generalized dystonia. J Korean Neurosurg Soc 2012;52(3):261–263. doi:10.3340/jkns.2012.52.3.261. PMID 23115674. Full text (PMC) verified
  7. Vayssiere N, Hemm S, Cif L, et al. Comparison of atlas- and magnetic resonance imaging-based stereotactic targeting of the globus pallidus internus in the performance of deep brain stimulation for treatment of dystonia. J Neurosurg 2002;96(4):673–679. doi:10.3171/jns.2002.96.4.0673. PMID 11990806. verified
  8. Vasques X, Cif L, Hess O, et al. Prognostic value of globus pallidus internus volume in primary dystonia treated by deep brain stimulation. J Neurosurg 2009;110(2):220–228. doi:10.3171/2008.3.17433. PMID 19012480. verified
  9. Trenado C, Nikolov P, Slotty PJ, et al. Intraoperative DBS targeting of the globus pallidus internus by using motor evoked potentials. J Neurol Sci 2024;463:123141. doi:10.1016/j.jns.2024.123141. PMID 39043070. verified
  10. Starr PA, Markun LC, Larson PS, et al. Interventional MRI-guided deep brain stimulation in pediatric dystonia: first experience with the ClearPoint system. J Neurosurg Pediatr 2014;14(4):400–408. doi:10.3171/2014.6.PEDS13605. PMID 25084088. verified
  11. Sharma VD, Bezchlibnyk YB, Isbaine F, et al. Clinical outcomes of pallidal deep brain stimulation for dystonia implanted using intraoperative MRI. J Neurosurg 2020;133(5):1582–1594. doi:10.3171/2019.6.JNS19548. PMID 31604331. verified
  12. David R, Scala MR, Ellenbogen J, et al. Review of the targeting accuracy of frameless and frame-based robot-assisted deep brain stimulation electrode implantation in pediatric patients using the Neurolocate module. J Neurosurg Pediatr 2024;33(3):207–213. doi:10.3171/2023.10.PEDS23275. PMID 38134418. verified
  13. Alterman RL, Miravite J, Weisz D, et al. Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology 2007;69(7):681–688. doi:10.1212/01.wnl.0000267430.95106.ff. PMID 17698790. verified
  14. Mulroy E, Vijiaratnam N, De Roquemaurel A, et al. A practical guide to troubleshooting pallidal deep brain stimulation issues in patients with dystonia. Parkinsonism Relat Disord 2021;87:142–154. doi:10.1016/j.parkreldis.2021.05.017. PMID 34074583. verified
  15. Ågren R, Bartek J, Johansson A, et al. Pulse width and implantable pulse generator longevity in pallidal deep brain stimulation for dystonia: a population-based comparative effectiveness study. Stereotact Funct Neurosurg 2020;98(5):331–336. doi:10.1159/000508794. PMID 32668433. verified
  16. Lange F, Guarin DL, Mosert S, et al. Bradykinesia induced by pallidal neurostimulation in dystonia: clinical risk factors and anatomical mapping. NPJ Parkinsons Dis 2025;11(1):308. doi:10.1038/s41531-025-01177-8. PMID 41131044. verified
  17. Jensen MA, Neimat JS, Kerezoudis P, et al. Principles of stereotactic surgery. Oper Neurosurg 2025;28(3):303–321. doi:10.1227/ons.0000000000001422. PMID 39627171. Full text (PMC) verified
  18. Mirzadeh Z, Chapple K, Lambert M, et al. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus. J Neurosurg 2016;124(4):902–907. doi:10.3171/2015.4.JNS1550. PMID 26452116. verified
  19. Chen T, Mirzadeh Z, Chapple KM, et al. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg 2018;130(1):109–120. doi:10.3171/2017.8.JNS17883. PMID 29547091. verified

Verification (2026-11-02): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. Reference 6 and reference 11 include adults (reference 11 is adults only). The chart combines values from references 3, 5, 9 and 10, which differ in design and follow-up. "Bilateral GPi is the standard" reflects the target used in references 3, 11 and 15 (GPi in 68 of 77 status dystonicus cases); the posteroventral location is from references 11 and 15. The targeting section (references 18–33) was added on 2026-11-02. The indirect coordinates come from the full text of reference 22 (a series of patients with primary dystonia, ages not stated in the abstract) and the pediatric example from the full text of reference 23. References 19, 20, 24, 25, 26, 28, 30–33 are adult or mixed-age. The location of the optic tract beneath GPi and the internal capsule medial to it is standard anatomy, given without a citation. References 34–36 (Ponce FA is a coauthor of 34 and senior author of 35; 36 is from the same group) were added at Dr. Hauptman's request. The landmark and physiology statements come from the full text of reference 34 on PMC. References 35 and 36 are adult Parkinson disease series. Specific millimeter distances from the internal capsule and the dorsal border of the optic tract, as used by Ponce's group, could not be verified from accessible abstracts or full texts and are not given. The chart and the coronal schematic are original figures.